Published Apr 27, 2026, 7:25 AM ET · Updated 7 months ago · 1 source
Novo-Backed Biotech Hemab Seeks to Raise $212 Million in US IPO
bloomberg
·
Original Report
INFERY
Hemab Therapeutics Holdings Inc., a clinical-stage biotechnology company, is seeking to raise as much as $212 million in a US initial public offering.